Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Bilirubin Blood Test Market from 2025 to 2034, and What Factors Influence It?

The market size for the bilirubin blood test has seen substantial growth recently. There is an expected increase from $1.37 billion in 2024 to $1.47 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.7%. The significant growth during the historical period can be credited to heightened instances of liver diseases, improvements in neonatal care, technology enhancements, increased health consciousness, advancements in healthcare infrastructure, necessary regulatory permissions and guidelines, along with heightened utilization of point-of-care testing.

The market for bilirubin blood test is expected to witness substantial growth in the coming years, expanding to $1.96 billion in 2029 with a compounded annual growth rate (CAGR) of 7.5%. This growth for the projected period is likely due to an increasing need for early diagnosis, enlargement of diagnostic labs, a rise in chronic disease occurrences, growth in emerging markets, the incorporation of sophisticated analytics, and more research funding. Key trends for the upcoming period encompass the progression of non-invasive testing techniques, amalgamation with digital health solutions, advancements in home testing kits, improved test precision and rapidity, personalized medicine strategies, intelligent diagnostic devices, and the inception of portable devices.

What External and Internal Drivers Are Contributing to the Growth of the Bilirubin Blood Test Market’s Growth?

The surge in liver disease cases is projected to accelerate the expansion of the bilirubin blood test market. Liver diseases encompass a variety of conditions that disrupt the liver’s proper functioning, resulting from multiple factors like infections, excessive drinking, and metabolic disorders. The escalation in liver disease incidences can be linked to the increasing prevalence of obesity, overconsumption of alcohol, viral infections, and poor lifestyle habits, all of which collectively lead to liver malfunction and damage. Elevated bilirubin levels can be a significant indicator of liver disease, with bilirubin blood tests offering a key diagnostic and monitoring tool for healthcare providers to effectively manage and treat liver-related conditions. For example, data from the European Centre for Disease Prevention and Control, a health agency based in Sweden, discloses that in April 2024, there were 28,855 recorded hepatitis B virus (HBV) infection cases across 30 EU/EEA Member States in 2022, marking a 78% rise from 16,187 cases in 2021. Furthermore, with a total of 28,420 cases in 2022, the crude incidence rate stood at 8.5 cases per 100,000 people. Consequently, the escalating rate of liver diseases is promoting growth in the bilirubin blood test market.

Explore Comprehensive Insights Into The Global Bilirubin Blood Test Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

Who Are the Leading Players Fueling Growth in the Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are:

• F.Hoffmann-La Roche Ltd_x000D_

• Thermo Fisher Scientific Inc._x000D_

• Abbott Laboratories_x000D_

• Danaher Corporation_x000D_

• Siemens Healthineers AG_x000D_

What Are the Emerging Trends Shaping the Future of the Bilirubin Blood Test Market?

Prominent firms in the bilirubin blood test market are employing a strategic partnership method to broaden their scope and improve their services. A strategic partnership often entails a cooperative interaction between two or more firms, pooling their resources, skills, and endeavors to realize mutual aims or targets. For example, in December 2023, an exclusive distributor contract for Calmark’s bilirubin test intended for newborns was signed by Calmark Sweden AB, a medical diagnostic biotech solutions corporation based in Israel, and Techno Orbits in Saudi Arabia. Techno Orbits will be in charge of the product’s distribution and sales, utilizing its existing connections and alliances, including those with the Ministry of Health. The partnership’s primary objective is to expedite the launch of Calmark’s bilirubin test in the Saudi market, with regulatory registration expected to take about 3 to 6 months.

Secure Your Global Bilirubin Blood Test Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Key Segments Stand Out in Understanding the Composition of the Bilirubin Blood Test Market?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Which Regions Are Driving Growth in the Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Bilirubin Blood Test Market Defined Across Different Regions?

The bilirubin blood test refers to a diagnostic procedure used to measure the levels of bilirubin in the blood. This test helps in assessing liver function and diagnosing conditions such as jaundice and liver disease. It is essential for evaluating bilirubin metabolism and detecting abnormalities related to liver health.

Browse Through More Similar Reports By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Patient Blood Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Anemia And Other Blood Disorder Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: